FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
This Quarter Return
+16.64%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$407M
AUM Growth
+$407M
(+26%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
40.45%
Top 10 Holdings %
Top 10 Hldgs %
90.6%
Holding
20
New
3
Increased
3
Reduced
3
Closed
4
Top Buys
| 1 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$144M |
| 2 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$40.7M |
| 3 |
Compass Therapeutics
CMPX
|
$13.9M |
| 4 |
Adicet Bio
ACET
|
$11.9M |
| 5 |
Hims & Hers Health
HIMS
|
$4.26M |
Top Sells
| 1 |
Cullinan Oncology
CGEM
|
$24.5M |
| 2 |
Nurix Therapeutics
NRIX
|
$13.5M |
| 3 |
PHICU
Population Health Investment Co., Inc. Unit
PHICU
|
$5.6M |
| 4 |
Pharvaris
PHVS
|
$4.75M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$2.49M |
Sector Composition
| 1 | Healthcare | 96.05% |
| 2 | Consumer Staples | 2.75% |
| 3 | Financials | 1.2% |
